|
|
||||||||

*
Department of Pathology, University of Geneva, Geneva, Switzerland; and
Division of Rheumatology/Allergy and Clinical Immunology, Department of Internal Medicine, University of California, Davis, CA 95616
A high-level expression of a transgene,
Ead, encoding the I-Ed
-chain
is very effective in protection against murine lupus. To investigate
the specific contribution of select H-2 haplotypes on the
Ead transgene-mediated disease-suppressing
effect, we generated H-2 congenic (NZB x BXSB)F1
hybrid mice bearing either H-2b/b, H-2d/b, or
H-2d/d haplotype, and compared the transgene-mediated
protective effect on the clinical development (autoantibody production
and glomerulonephritis) of lupus in these F1 hybrids. The
level of protection was most remarkable in mice bearing the
I-E- H-2b/b haplotype but was only minimal in
I-E+ H-2d/d F1 hybrids. Additional
analysis demonstrated a marked suppression of lupus in I-E+
H-2k/k (MRL x BXSB)F1 hybrid mice,
indicating that the transgene is able to suppress autoimmune responses
even in mice already expressing I-E molecules at a homozygous level.
Our results indicate that the level of the transgene-mediated
protection is dependent on the host H-2 haplotype. This suggests that
the autoimmune suppressive activity of the
Ead transgene is likely to be determined
through the interaction of the transgene product with the host MHC
class II molecules, providing new insight into the role of MHC in
lupus-like autoimmunity.
This article has been cited by other articles:
![]() |
E. Martinez-Soria, M.-L. Santiago-Raber, L. Ho, T. Moll, and S. Izui Protection of Murine Systemic Lupus by the Ea Transgene without Expression of I-E Heterodimers J. Immunol., September 1, 2008; 181(5): 3651 - 3657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sekine, K. L. Graham, S. Zhao, M. K. Elliott, P. Ruiz, P. J. Utz, and G. S. Gilkeson Role of MHC-Linked Genes in Autoantigen Selection and Renal Disease in a Murine Model of Systemic Lupus Erythematosus J. Immunol., November 15, 2006; 177(10): 7423 - 7434. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martinez-Soria, N. Ibnou-Zekri, M. Iwamoto, M.-L. Santiago-Raber, S. Kikuchi, M. Kosco-Vilbois, and S. Izui Epitope-Dependent Inhibition of T Cell Activation by the Ea Transgene: An Explanation for Transgene-Mediated Protection from Murine Lupus J. Immunol., August 15, 2004; 173(4): 2842 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C T Ravirajan and D A Isenberg Transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus Lupus, December 1, 2002; 11(12): 843 - 849. [Abstract] [PDF] |
||||
![]() |
A. Snijders, D. G. Elferink, A. Geluk, A. L. van der Zanden, K. Vos, G. M. T. Schreuder, F. C. Breedveld, R. R. P. de Vries, and E. H. Zanelli An HLA-DRB1-Derived Peptide Associated with Protection Against Rheumatoid Arthritis Is Naturally Processed by Human APCs J. Immunol., April 15, 2001; 166(8): 4987 - 4993. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |